#Antibody

Céline Gounder, MD, ScM, FIDSA

celinegounder

1/ Should we give as many people one dose of the Pfizer and Moderna vaccines as possible? Or half as many people two doses of vaccine? It’s a data-free zone.https://twitter.com/CitizenCohn/status/1358075667573862401

Dr. Joel C. Miller

joel_c_miller

Since a recent "lockdowns don't have any impact" thread seemed to get some traction (including being retweeted by a friend of mine who is reasonably quantitative), I thought it would

Rajeev Venkayya MD

rvenkayya

THREADThere’s much debate around the UK's recommended use of the AZ vaccine with a two-dose schedule and flexible timing of second dose. Some thoughts on the AZ recommendation (not Pfizer)

Prof. Akiko Iwasaki

VirusesImmunity

What is the relevance of viral load in #COVID19 disease severity? A very talented @YaleMSTP student @SilvaJ_C found that saliva viral load to be a better predictor of disease than

Thomas Dvorak

thomdvorak

Covid-19 IFR is *NOT* 0.13% (THREAD)There's a lot of confusion and some downright appalling falsehoods in the heated debate about Covid-19. One particular point around which the "let the virus

Anh Hoang Le

AnhHLe2702

Yayy, my first ever preprint is now online. Here we discover an unexpected new regulator for macropinocytosis, CYRI-A. If you like imaging and actin, this is for you :) Tweetorial

Prof Francois Balloux

BallouxFrancois

Antibody-Dependent Enhancement (ADE) is a complex and poorly understood phenomenon, likely underpinned by different mechanisms, where binding of a virus to suboptimal antibodies enhances severity of the disease, rather than

Zach Thompson, MD

TZThompsonMD

1/ TIL about acquired hemophilia A (AH), a condition in which an auto-antibody of factor VIII is formed resulting in profound risk of bleeding. Early suspicion and treatment are critical

Prathit Kulkarni, MD

PrathitKulkarni

List of the most common questions I am getting regarding #CovidVaccine. Here's a shot at answering them. Hope they are helpful! Many answers I got from recently available @CDCgov material.

Joseph Allen

j_g_allen

THREAD on positive #COVIDー19 developments(I try to keep a runny tally in my head - helps get through the days, knowing there is a light at the end)1. Therapeutics are

Vincent Rajkumar

VincentRK

I’m convinced that seroprevalence studies greatly underestimate the true level of immunity of a given population to COVID. Take Sweden: point is not whether they did the right thing. I

Deepta Bhattacharya

deeptabhattacha

I received this email from someone last week that I can't stop thinking about. I probably received this since I have been openly optimistic about vaccine efforts. So I wanted

Simon Cleary

Simon_J_Cleary

New research out in @JClinicalInvest! Critical roles for endothelial antigen and complement in a model of antibody-mediated lung injury + imaging of #ARDS lung pathology initiation #InMice @UCSF @immunox. Free

Condorito

Arquitect3

1/ THREAD: Long ImmunoPrecise Antibodies (IPA- Nasdaq)$IPA is my largest holding since mid-2020, I haven't sold a shareThis thread is just the peak of the iceberg as IPA has made

Joshua Bauml, MD

Jbauml

Next up @JSabari is presenting data on amivantamab in EGFR Exon20ins+ NSCLC. I have participated in the development of amivantamab, though I am not on this particular abstract. Excited to

Shane Crotty

profshanecrotty

Well, that's a nice surprise!What happens if you have had COVID infection before and you get a COVID vaccine? Some observations last week are summarized here:https://twitter.com/profshanecrotty/status/1356623349862989827?s=20 In a new p

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.